Accessibility helpSkip to navigationSkip to contentSkip to footer

Cookies on FT Sites

We use cookies and other data for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.

Accept cookies
Manage cookies
  • Sign In
  • Subscribe
Open side navigation menuOpen search bar
Financial Times
SubscribeSign InmyFT
  • Home
  • World
    Sections
    • World Home
    • Global Economy
    • UK
    • US
    • China
    • Africa
    • Asia Pacific
    • Emerging Markets
    • Europe
    • War in Ukraine
    • Americas
    • Middle East & North Africa
    • Australia & NZ
    Most Read
    • Wildfire smoke makes New York air quality worst in the world
    • Turkish lira slumps as new economic team starts ‘intentional devaluation’
    • OECD chief economist calls for governments to cut fiscal support
    • US-bound Air India passengers face tense wait after landing in Russia
    • Antony Blinken to visit China this month in sign of easing tensions
  • US
    Sections
    • US Home
    • US Economy
    • US Companies
    • US Politics & Policy
    Most Read
    • Companies
      Sections
      • Companies Home
      • Energy
      • Financials
      • Health
      • Industrials
      • Media
      • Professional Services
      • Retail & Consumer
      • Tech Sector
      • Telecoms
      • Transport
      Most Read
      • Telegraph titles set to be sold after Lloyds calls in receivers
      • Chris Licht out as CNN chief after series of stumbles
      • New York sues Hyundai and Kia over ‘explosion’ of car thefts
      • Diageo chief Ivan Menezes dies
      • Saudi Arabia to spend billions on shock merger of PGA Tour and LIV Golf
    • Tech
    • Markets
      Sections
      • Markets Home
      • Alphaville
      • Markets Data
      • Cryptofinance
      • Capital Markets
      • Commodities
      • Currencies
      • Equities
      • Fund Management
      • Trading
      • Moral Money
      • ETF Hub
      Most Read
      • Live news updates from June 7: Wildfire smoke blankets New York, China exports decline
      • US Treasury’s $1tn borrowing drive set to put banks under strain
      • Turkish lira slumps as new economic team starts ‘intentional devaluation’
      • Nvidia’s rally forces money managers to play catch-up
      • A (very short) history of global reserve currencies
    • Climate
    • Opinion
      Sections
      • Opinion Home
      • Columnists
      • The FT View
      • Lex
      • Obituaries
      • Letters
      Most Read
      • The myth of the ‘Asian century’
      • The paranoid style in American politics
      • As the world swirls, Saudi Arabia repositions itself as a global linchpin
      • Dam breach gives Russia a new weapon in Ukraine war
      • Don’t blame the west if the global south goes its own way
    • Work & Careers
      Sections
      • Work & Careers Home
      • Business School Rankings
      • Business Education
      • Entrepreneurship
      • Recruitment
      • Business Books
      • Business Travel
      Most Read
      • Too good to be true? The fake recruiters targeting jobseekers
      • Anti-monarchist Graham Smith: The British royals are ‘tax-funded Kardashians’
      • Can a virtual PA turbocharge your career?
      • FT business books: what to read this month
    • Life & Arts
      Sections
      • Life & Arts Home
      • Arts
      • Books
      • Food & Drink
      • FT Magazine
      • House & Home
      • Style
      • Travel
      • FT Globetrotter
      Most Read
      • Why motorcycle gangs will end with a whimper, not a rev
      • Men, where to find the perfect T-shirt
      • How Crispin Odey evaded sexual assault allegations for decades
      • Charlie Brooker on satirising TV in Black Mirror: ‘If it wasn’t on Netflix, we’d be sued’
      • The summer suit just got a lot more seductive
    • HTSI
    MenuSearch
    • Home
    • World
    • US
    • Companies
    • Tech
    • Markets
    • Climate
    • Opinion
    • Work & Careers
    • Life & Arts
    • HTSI
    Financial Times
    SubscribeSign In

    Medical science

    Add to myFT Digest

    Add this topic to your myFT Digest for news straight to your inbox

    • Saturday, 3 June, 2023
      ObituaryHarald zur Hausen
      Harald zur Hausen, virologist, 1936-2023

      Nobel Prize winner who discovered the cause of cervical cancer in humans

    • Friday, 2 June, 2023
      Cannabis industry
      UK medical cannabis group woos patients to buy into the business

      Isle of Man’s GLO wants to sell 25 per cent to clients, letting them influence production

    • Friday, 2 June, 2023
      Health sector
      More than 400 Grail patients incorrectly told they may have cancer

      Error prompts life assurance customers to pause or review relationship with early detection biotech

    • Friday, 2 June, 2023
      David Strain
      Vaping as a cure for smoking has brought its own ills

      Marketing attractive nicotine products to children risks a whole generation’s health

    • Thursday, 1 June, 2023
      Genomics
      ‘Primate AI algorithm’ predicts genetic health risks

      Scientists apply deep learning to expanded DNA database to help identify disease-causing mutations in humans

    • Thursday, 1 June, 2023
      Mariana Mazzucato
      Preparing for the next pandemic will take a global commitment

      The leaked draft of the WHO Pandemic Accord contains worrying signs

    • Thursday, 1 June, 2023
      Helen Thomas
      Ailing UK life sciences sector will need further treatment

      Policy prescriptions are plentiful but momentum and money behind them is lacking

    • Tuesday, 30 May, 2023
      Coronavirus
      China investigated Covid lab leak claims, says top scientist

      Health official’s admission undermines Beijing’s dismissals that virus could have emerged from Wuhan facility

    • Wednesday, 24 May, 2023
      Biotech
      UK to announce funding boost for life sciences

      Government seeks to win over pharma groups with new investments in genomics research and drug manufacturing

    • Wednesday, 24 May, 2023
      The FT ViewThe editorial board
      Investors can play their part in the war on superbugs

      As McDonald’s is targeted, governments also need to tighten and enforce rules

    • Wednesday, 24 May, 2023
      AI-based ‘digital bridge’ enables paraplegic patient to walk

      Neurotechnology restores natural gait with device that decodes brain’s signals for people with spinal injuries

    • Tuesday, 23 May, 2023
      Anjana Ahuja
      New surgical procedure makes us question what it means to be alive

      The organ recovery technique has provoked criticism from within the scientific community

    • Wednesday, 17 May, 2023
      The Big Read
      Quick blood tests to spot cancer: will they help or harm patients?

      Investors are pouring billions into companies claiming they can analyse DNA to find the disease early. But some scientists question if they really work

    • Sunday, 14 May, 2023
      Dementia
      Japan pushes for strong pledges on tackling dementia from G7 allies

      Alzheimer’s advocates call for ambitious declaration to match the scope of commitments made 10 years ago

    • Friday, 12 May, 2023
      UK politics & policy
      ‘Cultural sniffiness’ over profit is hurting NHS drug trials, Labour warns

      Shadow health secretary sets out plan to boost clinical research

    • Friday, 12 May, 2023
      Simon Schama
      The thwarting of science will always be a human failing

      From India to Britain, we have always managed to get in the way of our own inventiveness

    • Thursday, 11 May, 2023
      Mpox
      Mpox is no longer a global health emergency, says WHO

      Viral disease previously known as monkeypox has caused more than 87,000 infections and 140 deaths

    • Thursday, 11 May, 2023
      Science
      Study reveals scale of ‘science scam’ in academic publishing

      One in 5 biomedical articles may contain faked data, with Chinese paper mills leading way

    • Wednesday, 10 May, 2023
      Genomics
      Expanded ‘pan-genome’ database aims to improve treatment of diseases

      Project discovers more variation in DNA than expected, offering insights into human diversity

    • Monday, 8 May, 2023
      Dementia
      Two Alzheimer’s drugs offer hope to patients after decades of waiting

      In clinical trials, the medications slowed the progress of the degenerative disease that affects 50mn worldwide

    • Friday, 5 May, 2023
      Coronavirus
      WHO says Covid-19 emergency is over

      UN health body declares end to acute phase of pandemic after at least 20mn deaths

    • Friday, 5 May, 2023
      Wellcome Trust
      Wellcome Trust to triple size of Cambridge genome campus

      Biggest biomedical charity makes first investment in science infrastructure from its endowment

    • Friday, 28 April, 2023
      Special Report
      The Americas’ Fastest Growing Companies

      The FT’s fourth annual ranking of the region’s businesses by revenue growth. Plus: companies with the ‘last-mover advantage’; cannabis corporations on the rise; is Moderna a one trick pony?

    • Wednesday, 26 April, 2023
      US regulators approve first human pill derived from faecal matter

      FDA gives green light to C. difficile treatment in boost for microbiome drug developers

    • Friday, 21 April, 2023
      Roe vs Wade
      US Supreme Court pauses restrictions on abortion pill

      Decision halts limitations imposed by a Texas judge earlier this month

    Previous page You are on page 1 Next page

    Be part of FT Community

    Discover unmissable flagship events and members only communities to expand your thinking and elevate your career

    FT Live
    Transforming Approaches to Triple-Negative Breast Cancer
    Raising awareness, innovating treatments and improving patient support
    Thursday, 8th JuneOnline
    FT Live
    Clinical Data Management in Healthcare & Life Sciences Research
    Innovating and adapting as technology evolves
    Tuesday, 27th JuneOnline
    FT Live
    US Pharma and Biotech Summit
    Exploring trends and innovations in life sciences across the United States
    Tuesday, 14th May 2024New York, US & Online
    Learn more about FT Community

    Useful links

    Support

    View Site TipsHelp CentreContact UsAbout UsAccessibilitymyFT TourCareers

    Legal & Privacy

    Terms & ConditionsPrivacy PolicyCookiesCopyrightSlavery Statement & Policies

    Services

    Share News Tips SecurelyIndividual SubscriptionsGroup SubscriptionsRepublishingExecutive Job SearchAdvertise with the FTFollow the FT on TwitterFT ChannelsFT Schools

    Tools

    PortfolioToday's Newspaper (ePaper)Alerts HubBusiness School RankingsEnterprise ToolsNews feedNewslettersCurrency Converter

    Community & Events

    FT CommunityFT Live EventsFT ForumsFT Board DirectorBoard Director Programme

    More from the FT Group

    Markets data delayed by at least 15 minutes. © THE FINANCIAL TIMES LTD 2023. FT and ‘Financial Times’ are trademarks of The Financial Times Ltd.
    The Financial Times and its journalism are subject to a self-regulation regime under the FT Editorial Code of Practice.
    Financial Times

    International Edition

    Subscribe for full access
    • Switch to UK Edition

    Top sections

    • Home
    • World
      • Global Economy
      • UK
      • US
      • China
      • Africa
      • Asia Pacific
      • Emerging Markets
      • Europe
      • War in Ukraine
      • Americas
      • Middle East & North Africa
      • Australia & NZ
    • US
      • US Economy
      • US Companies
      • US Politics & Policy
    • Companies
      • Energy
      • Financials
      • Health
      • Industrials
      • Media
      • Professional Services
      • Retail & Consumer
      • Tech Sector
      • Telecoms
      • Transport
    • Tech
    • Markets
      • Alphaville
      • Markets Data
      • Cryptofinance
      • Capital Markets
      • Commodities
      • Currencies
      • Equities
      • Fund Management
      • Trading
      • Moral Money
      • ETF Hub
    • Climate
    • Opinion
      • Columnists
      • The FT View
      • Lex
      • Obituaries
      • Letters
    • Work & Careers
      • Business School Rankings
      • Business Education
      • Entrepreneurship
      • Recruitment
      • Business Books
      • Business Travel
    • Life & Arts
      • Arts
      • Books
      • Food & Drink
      • FT Magazine
      • House & Home
      • Style
      • Travel
      • FT Globetrotter
    • Personal Finance
      • Property & Mortgages
      • Investments
      • Pensions
      • Tax
      • Banking & Savings
      • Advice & Comment
      • Next Act
    • HTSI
    • Special Reports

    FT recommends

    • Lex
    • Alphaville
    • Lunch with the FT
    • FT Globetrotter
    • #techAsia
    • Moral Money
    • Newsletters
    • Video
    • Podcasts
    • News feed
    • FT Live Events
    • FT Forums
    • Board Director Programme
    • myFT
    • Portfolio
    • Today's Newspaper (ePaper)
    • Crossword
    • Our Apps
    • Help Centre
    • Subscribe
    • Sign In